Publication | Closed Access

Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

HepatologyPharmacologyPharmacological IssueNon-alcoholic SteatohepatitisPhase 1B/2aPharmacotherapyHepatotoxicityMultiple-ascending-dose StudyMedicineDrug-induced Liver Injury